# Nuclide record alsympca (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/alsympca/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "alsympca", "NCT00699751" ;
  schema:name "ALSYMPCA"@en ;
  schema:description "ALSYMPCA is the trial that won approval for the first alpha-emitting drug."@en ;
  schema:url <https://nuclide.cc/trials/alsympca/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00699751> ;
  nuclide:status "positive" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/isotopes/ac-225/>, <https://nuclide.cc/isotopes/ra-223/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-mcrpc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/> ;
  nuclide:drugs <https://nuclide.cc/drugs/radium-223/> ;
  nuclide:people <https://nuclide.cc/people/oliver-sartor/>, <https://nuclide.cc/people/karim-fizazi/> .